$1 Trial Offer - Realtime Screener -- Try out our Realtime Product, GetStockIdeas. The advanced screener tool is a momentum trader's dream!

Pharmacyclics, Inc.
(NASDAQ : PCYC)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
Loading PCYC News...
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
BMYBristol-Myers Squibb Company
0.05%58.790.6%$968.82m
PFEPfizer Inc.
0.17%34.830.7%$735.33m
JNJJohnson & Johnson
0.40%119.040.8%$722.76m
MRKMerck & Co., Inc.
0.87%62.861.1%$715.86m
ABBVAbbVie, Inc.
-0.16%64.622.9%$438.10m
LLYEli Lilly and Company
0.32%78.260.7%$249.27m
AZNAstraZeneca PLC Sponsored ADR
-0.54%33.051.2%$207.47m
NVONovo Nordisk A/S Sponsored ADR Class B
0.11%46.900.1%$160.08m
GSKGlaxoSmithKline plc Sponsored ADR
-0.45%43.550.3%$109.04m
NVSNovartis AG Sponsored ADR
-0.34%79.280.2%$91.32m
SNYSanofi Sponsored ADR
0.92%38.810.1%$68.87m
LCILannett Company, Inc.
-1.72%34.2320.3%$36.69m
SCMPSucampo Pharmaceuticals, Inc. Class A
0.36%11.073.8%$3.78m
AKTXAkari Therapeutics Plc Sponsored ADR
-4.95%9.590.2%$0.04m
EPIXESSA Pharma Inc
-2.26%2.600.0%$0.01m

Company Profile

Pharmacyclics LLC engages in developing and commercializing innovative small-molecule drugs for the treatment of cancer and immune mediated diseases. The company has three product candidates in clinical development and several preclinical molecules in lead optimization. Its clinical development and product candidates are small-molecule enzyme inhibitors designed to target key biochemical pathways involved in human diseases with critical unmet needs. Pharmacyclics was founded on April 19, 1991 and is headquartered in Sunnyvale, CA.